Dr. Lal PathLabs Ltd Q2FY25 consolidated net profit increases to Rs. 129.2 crores

Dr. Lal Path Labs Ltd. has reported Consolidated financial results for the period ended September 30, 2024.

Financial Results (Q2 FY2025) - QoQ Comparison

The company has reported total income of Rs. 682.1 crores during the period ended September 30, 2024 as compared to Rs. 622.5 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs. 129.2 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 106.4 crores for the period ended June 30, 2024.

The company has reported EPS of Rs. 15.48 for the period ended September 30, 2024 as compared to Rs. 12.76 for the period ended June 30, 2024.

Financials	Q2 FY2025	Q1 FY2025	% Change
Total Income	₹682.1 crs	₹622.5 crs	9.57%
Net Profit	₹129.2 crs	₹106.4 crs	21.43%
EPS	₹15.48	₹12.76	21.32%

Financial Results (Q2 FY2025) - YoY Comparison

The company has reported total income of Rs.682.1 crores during the period ended September 30, 2024 as compared to Rs.619.4 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs.129.2 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.109.3 crores for the period ended September 30, 2023.

The company has reported EPS of Rs.15.48 for the period ended September 30, 2024 as compared to Rs.13.12 for the period ended September 30, 2023.

Financials	Q2 FY2025	Q2 FY2024	% Change
Total Income	₹682.1 crs	₹619.4 crs	10.12%
Net Profit	₹129.2 crs	₹109.3 crs	18.21%
EPS	₹15.48	₹13.12	17.99%

Financial Results (Half Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.1304.6 crores during the 6 Months period ended September 30, 2024 as compared to Rs.1174.8 crores during the 6 Months period ended September 30, 2023.

The company has posted net profit / (loss) of Rs.235.6 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.191.9 crores for the 6 Months period ended September 30, 2023.

The company has reported EPS of Rs.28.24 for the 6 Months period ended September 30, 2024 as compared to Rs.23.05 for the 6 Months period ended September 30, 2023.

Financials	Half Year Ended FY2025	Half Year Ended FY2024	% Change
Total Income	₹1304.6 crs	₹1174.8 crs	11.05%
Net Profit	₹235.6 crs	₹191.9 crs	22.77%
EPS	₹28.24	₹23.05	22.52%

Shares of Dr. Lal Path Labs Ltd. was last trading in BSE at Rs. 3252.50 as compared to the previous close of Rs. 3317.45. The total number of shares traded during the day was 7504 in over 1321 trades.

The stock hit an intraday high of Rs. 3336.85 and intraday low of 3238.20. The net turnover during the day was Rs. 24738046.00.

Source : Equity Bulls

Keywords

DrLalPathLabs Q2FY25 H1FY25 Q2FY2025 H1FY2025 ResultUpdate